August 19, 2024 / 11:55 IST
Reported Standalone quarterly numbers for Bafna Pharmaceuticals are:Net Sales at Rs 33.29 crore in June 2024 down 20.65% from Rs. 41.95 crore in June 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 0.72 crore in June 2024 down 111.39% from Rs. 6.35 crore in June 2023.
EBITDA stands at Rs. 1.71 crore in June 2024 down 79.04% from Rs. 8.16 crore in June 2023.
Bafna Pharma shares closed at 83.07 on August 16, 2024 (NSE) and has given -8.51% returns over the last 6 months and -19.35% over the last 12 months.
| Bafna Pharmaceuticals | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'24 | Mar'24 | Jun'23 | | Net Sales/Income from operations | 33.29 | 41.40 | 41.95 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 33.29 | 41.40 | 41.95 | | EXPENDITURE | | Consumption of Raw Materials | 18.37 | 23.79 | 19.56 | | Purchase of Traded Goods | -- | 1.65 | 6.65 | | Increase/Decrease in Stocks | 1.48 | -3.37 | -3.53 | | Power & Fuel | -- | -- | -- | | Employees Cost | 5.14 | 5.38 | 4.27 | | Depreciation | 1.44 | 1.27 | 1.21 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 7.10 | 11.07 | 8.69 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -0.23 | 1.62 | 5.08 | | Other Income | 0.51 | 0.52 | 1.87 | | P/L Before Int., Excpt. Items & Tax | 0.27 | 2.13 | 6.95 | | Interest | 0.65 | 0.68 | 0.60 | | P/L Before Exceptional Items & Tax | -0.38 | 1.46 | 6.35 | | Exceptional Items | -0.35 | -- | -- | | P/L Before Tax | -0.72 | 1.46 | 6.35 | | Tax | -- | -- | -- | | P/L After Tax from Ordinary Activities | -0.72 | 1.46 | 6.35 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -0.72 | 1.46 | 6.35 | | Equity Share Capital | 23.66 | 23.66 | 23.66 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.31 | 0.62 | 2.68 | | Diluted EPS | -0.31 | 0.62 | 2.68 | | EPS After Extra Ordinary | | Basic EPS | -0.31 | 0.62 | 2.68 | | Diluted EPS | -0.31 | 0.62 | 2.68 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
